FP-208, a novel mTOR inhibitor with potent antitumor activities

被引：0
|
作者：
Du, Zhenjian [1 ]
Ji, Qi [1 ]
Chen, Bo [1 ]
Zhang, Chunxiao [1 ]
Zhao, Ge [1 ]
Zhang, Xingmin [1 ]
机构：
[1] Foreland Pharma, Beijing, Peoples R China
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2667
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2667
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical candidate FP-208, a novel mTOR inhibitor with tolerable activity on PI3K
    Ji, Qi
    Du, Zhenjian
    Wang, Lei
    Gao, Congmin
    Gong, Longlong
    Chen, Bo
    Li, Yuchuan
    Zhang, Xingmin
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [2] Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities In Vitro and In Vivo
    Xie, Hua
    Lee, Mee-Hyun
    Zhu, Feng
    Reddy, Kanamata
    Huang, Zunnan
    Kim, Dong Joon
    Li, Yan
    Peng, Cong
    Lim, Do Young
    Kang, Soouk
    Jung, Sung Keun
    Li, Xiang
    Li, Haitao
    Ma, Weiya
    Lubet, Ronald A.
    Ding, Jian
    Bode, Ann M.
    Dong, Zigang
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (06) : 950 - 958
  • [3] UHPLC-MS/MS method to determine FP-208 in human plasma and its application to a pharmacokinetic study
    Wang, Huanhuan
    Wang, Teng
    Wang, Zhanqing
    Du, Zhenjian
    Zhao, Qian
    Jiang, Ji
    Hu, Pei
    [J]. BIOANALYSIS, 2020, 12 (06) : 367 - 378
  • [4] Novel Microtubule Polymerization Inhibitor with Potent Antiproliferative and Antitumor Activity
    Arora, Sonia
    Wang, Xin I.
    Keenan, Susan M.
    Andaya, Christina
    Zhang, Qiang
    Peng, Youyi
    Welsh, William J.
    [J]. CANCER RESEARCH, 2009, 69 (05) : 1910 - 1915
  • [5] A novel semi-synthetic mTOR pathway inhibitor with antitumor properties
    Morad, S. F. A.
    Schmid, M.
    Buechele, B.
    Pitterle, K.
    Syrovets, T.
    Simmet, T.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 381 : 42 - 42
  • [6] Novel pyrazolopyrimidine derivatives as potent mTOR kinase inhibitors with anticancer activities
    Chen, S.
    Meng, L.
    Liang, C.
    Ding, J.
    [J]. EJC SUPPLEMENTS, 2010, 8 (07): : 54 - 54
  • [7] Kedarcidin and maduropeptin, two novel chromoproteins with potent antitumor activities.
    Zein, N
    [J]. DNA AND RNA CLEAVERS AND CHEMOTHERAPY OF CANCER AND VIRAL DISEASES, 1996, 479 : 53 - 63
  • [8] ZM-2311 a novel and highly potent Pol θ inhibitor demonstrates synergistically antitumor activities in combination with different therapeutics
    Zhou, Feng
    Liu, Lu
    Jiang, Lei
    Qian, Shuo
    Xue, Liting
    Li, Mengying
    Li, Zhengtao
    Li, Zhen
    Li, Jian
    Tang, Renhong
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [9] FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor
    Nakajima, H
    Kim, YB
    Terano, H
    Yoshida, M
    Horinouchi, S
    [J]. EXPERIMENTAL CELL RESEARCH, 1998, 241 (01) : 126 - 133
  • [10] Ecubectedin is a novel transcriptional inhibitor that displays potent antitumor effects in vitro and in vivo
    Nunez, Gema Santamaria
    Diez, Marta Martinez
    Guillen, Maria Jose
    Garrido-Martin, Eva Maria
    Aviles, Pablo
    Cuevas, Carmen
    [J]. CANCER RESEARCH, 2023, 83 (07)
12345